Our Team
Professor Michael Scott
He was awarded the Guild of Healthcare Pharmacists gold medal for outstanding contribution to the health service at national level in 2010. In 2014 he received the special achievement award from the Ulster Chemists Association for outstanding contribution to the development of pharmacy in Northern Ireland. In 2016 he was awarded the United Kingdom Clinical Pharmacy Association Lifetime Achievement Award. Most recently in 2019 he received the David Samways Award from the Guild of Healthcare Pharmacists in recognition of outstanding National Contribution to the practice of pharmacy procurement.
Dr. Glenda Fleming
Dr. Glenda Fleming studied pharmacy at Queen’s, Belfast and after completing pre-registration training and registering with the PSNI, returned to Queen’s to undertake a PhD. Following a short period of working as research fellow for the Northern Ireland Centre for Postgraduate Pharmaceutical Education and Training (NICPPET) she moved to HSC R&D Office where she worked as a Programme Manager. In this role she contributed to the implementation of the HSC R&D Strategy, developed policies and procedures governing the conduct of R&D; and provided leadership in the co-ordination of pharmaceutical R&D throughout NI. Dr Fleming is currently Deputy Director for the Medicines Optimisation Innovation Centre (MOIC). During her career she has gained over 16 years of experience, on a part-time basis, in community pharmacy and has taught at undergraduate and postgraduate levels.
Anita Hogg
Anita Hogg has undertaken research in medicines management and delivered a number of quality and medicines optimisation programmes since joining the hospital sector in 2001. She was pharmacist co-ordinator of the award winning Integrated Medicines Management programme within the Northern Health and Social Care Trust and supported the implementation and development of this work across Northern Ireland and in Europe. In 2002 she won the Northern Ireland Hospital Pharmacist of the Year Award and has published research papers and presented work on medicines management both nationally and internationally. She qualified as an Independent Prescriber in 2009 and has delivered postgraduate education and training throughout her career. Prior to joining the hospital sector, Anita worked with the Northern Health and Social Services Board on a sessional basis undertaking medicine reviews within the surgery setting and providing prescribing advice to General Practitioners. She was one of the first pharmacists to deliver the community pharmacy based ‘Managing Your Medicines’ service. During an attachment as Principal Pharmaceutical Officer, DHSSPS, Anita Hogg supported the implementation and delivery of the Pharmaceutical Clinical Effectiveness Programme in Northern Ireland. She is currently the Pharmaceutical Clinical Effectiveness lead for the Medicines Optimisation Innovation Centre (MOIC) and continues to undertake research and deliver a medicines management service to outpatients.
Dr. Rachel Huey
Senior Research and Innovation Programme Manager.
Dr. Rachel Huey is a registered pharmacist and has worked in both community and hospital settings. Rachel’s PhD focused on pharmaceutics and targeted formulation development to treat neurodegenerative disease.
Dr. Claire Scullin
Dr Claire Scullin is an experienced researcher. She is an economics graduate (BSc economics / MSc finance) and also holds a PhD in clinical pharmacy. She is GCP trained and has been involved in the evaluation of the Integrated Medicines Management (IMM) system for inpatients together with other hospital and community based quality improvement projects.
Dr. Nicola Goodfellow
Dr Nicola Goodfellow studied pharmacy at the University of Nottingham. After graduating and registering with the Pharmaceutical Society of Northern Ireland Nicola joined Queen’s University Belfast (QUB) to undertake a PhD on medicines adherence in children with cystic fibrosis. Following this, Dr Goodfellow worked as a post-doctoral research assistant in QUB before joining the Northern Ireland Clinical Trials Unit where she monitored and managed a portfolio of large, multi-centre clinical trials. In 2018, Nicola joined the Medicine Optimisation Innovation Centre as a Senior Research and Innovation Programme Manager and most recently has been involved in a large EU-funded Innovation Action (SHAPES), service evaluations and reporting for the Department of Health NI.
Dr Nicola Goodfellow studied pharmacy at the University of Nottingham. After graduating and registering with the Pharmaceutical Society of Northern Ireland Nicola joined Queen’s University Belfast (QUB) to undertake a PhD on medicines adherence in children with cystic fibrosis. Following this, Dr Goodfellow worked as a post-doctoral research assistant in QUB before joining the Northern Ireland Clinical Trials Unit where she monitored and managed a portfolio of large, multi-centre clinical trials. In 2018, Nicola joined the Medicine Optimisation Innovation Centre as a Senior Research and Innovation Programme Manager and most recently has been involved in a large EU-funded Innovation Action (SHAPES), service evaluations and reporting for the Department of Health NI.
Rachel is a registered pharmacist and has worked in both community and hospital settings. Rachel’s PhD focused on pharmaceutics and targeted formulation development to treat neurodegenerative disease.
Rachel also has a black belt in martial arts.
Glenda Fleming studied pharmacy at Queen’s, Belfast and after completing pre-registration training and registering with the PSNI, returned to Queen’s to undertake a PhD. Following a short period of working as research fellow for the Northern Ireland Centre for Postgraduate Pharmaceutical Education and Training (NICPPET) she moved to HSC R&D Office where she worked as a Programme Manager. In this role she contributed to the implementation of the HSC R&D Strategy, developed policies and procedures governing the conduct of R&D; and provided leadership in the co-ordination of pharmaceutical R&D throughout NI. Dr Fleming is currently Deputy Director for the Medicines Optimisation Innovation Centre (MOIC). During her career she has gained over 16 years of experience, on a part-time basis, in community pharmacy and has taught at undergraduate and postgraduate levels.
Dr. Joanne Brown
Dr. Joanne Brown qualified as a pharmacist in 1997 from Queen’s University, Belfast, and worked in community pharmacy before returning to the School of Pharmacy at Queen’s to undertake a PhD in 1999. She has worked in hospital pharmacy since 2002. Most recent roles include Clinical Education Pharmacist, deployment to palliative care during the Covid-19 pandemic and iSIMPATHY project pharmacist. She is an independent prescriber and is passionate about supporting patients and pharmacy teams to optimise outcomes. Joanne is vice-chair of the European Society of Clinical Pharmacy Education Committee and an honorary senior lecturer at Queen’s. She was the inaugural winner of the Royal Pharmaceutical Society Barnett award in 2024 for professional development excellence within pharmacy.
Dr. Joanne Brown is a Senior Research and Innovation Programme Manager at MOIC. She qualified as a pharmacist in 1997 from Queen’s University, Belfast, and worked in community pharmacy before returning to the School of Pharmacy at Queen’s to undertake a PhD in 1999. She has worked in hospital pharmacy since 2002. Most recent roles include Clinical Education Pharmacist, deployment to palliative care during the Covid-19 pandemic and iSIMPATHY project pharmacist. She is an independent prescriber and is passionate about supporting patients and pharmacy teams to optimise outcomes. Joanne is vice-chair of the European Society of Clinical Pharmacy Education Committee and an honorary senior lecturer at Queen’s. She was the inaugural winner of the Royal Pharmaceutical Society Barnett award in 2024 for professional development excellence within pharmacy.
Dr. Joanne Brown is a Senior Research and Innovation Programme Manager at MOIC. She qualified as a pharmacist in 1997 from Queen’s University, Belfast, and worked in community pharmacy before returning to the School of Pharmacy at Queen’s to undertake a PhD in 1999. She has worked in hospital pharmacy since 2002. Most recent roles include Clinical Education Pharmacist, deployment to palliative care during the Covid-19 pandemic and iSIMPATHY project pharmacist. She is an independent prescriber and is passionate about supporting patients and pharmacy teams to optimise outcomes. Joanne is vice-chair of the European Society of Clinical Pharmacy Education Committee and an honorary senior lecturer at Queen’s. She was the inaugural winner of the Royal Pharmaceutical Society Barnett award in 2024 for professional development excellence within pharmacy.
Dr. Joanne Brown is a Senior Research and Innovation Programme Manager at MOIC. She qualified as a pharmacist in 1997 from Queen’s University, Belfast, and worked in community pharmacy before returning to the School of Pharmacy at Queen’s to undertake a PhD in 1999. She has worked in hospital pharmacy since 2002. Most recent roles include Clinical Education Pharmacist, deployment to palliative care during the Covid-19 pandemic and iSIMPATHY project pharmacist. She is an independent prescriber and is passionate about supporting patients and pharmacy teams to optimise outcomes. Joanne is vice-chair of the European Society of Clinical Pharmacy Education Committee and an honorary senior lecturer at Queen’s. She was the inaugural winner of the Royal Pharmaceutical Society Barnett award in 2024 for professional development excellence within pharmacy.
Katherine Redpath
Communications Manager
Katherine Redpath holds an MSC in Marketing Studies from Ulster University and has over 25 years of experience in marketing and communications.
Katherine has a proven track record in developing and implementing comprehensive marketing strategies across various industries, including ICT, education, social enterprise, and charity. Her experience encompasses a wide range of online and offline marketing channels.
Katherine holds an MSC in Marketing Studies from Ulster University and has over 25 years of experience in marketing and communications.
Katherine has a proven track record in developing and implementing comprehensive marketing strategies across various industries, including ICT, education, social enterprise, and charity. Her experience encompasses a wide range of online and offline marketing channels.
Elizabeth Hauxwell
Team Secretary
Dr. Suzanne Martin
Senior Research and Innovation Programme Manager
Dr. Suzanne Martin studied Physiotherapy at the Ulster University, followed by a Masters in Health Promotion and Population Health and in 2013 she received her PhD in Rehabilitation Science. Suzanne has over 10 years’ experience in both investigator and industry led research across the academic and healthcare settings. During her career she has gained experience in various research methodologies and has successfully managed a wide range of projects across a variety of settings including Clinical Trials of Investigational Medicinal Products (CTIMP).
Suzanne studied Physiotherapy at the Ulster University, followed by a Masters in Health Promotion and Population Health and in 2013 she received her PhD in Rehabilitation Science. Suzanne has over 10 years’ experience in both investigator and industry led research across the academic and healthcare settings. During her career she has gained experience in various research methodologies and has successfully managed a wide range of projects across a variety of settings including Clinical Trials of Investigational Medicinal Products (CTIMP).
Suzanne studied Physiotherapy at the Ulster University, followed by a Masters in Health Promotion and Population Health and in 2013 she received her PhD in Rehabilitation Science. Suzanne has over 10 years’ experience in both investigator and industry led research across the academic and healthcare settings. During her career she has gained experience in various research methodologies and has successfully managed a wide range of projects across a variety of settings including Clinical Trials of Investigational Medicinal Products (CTIMP).